EUVIMEDEUVIMED entdecken
Crossref

Airway epithelial-targeted nanoparticle reverses asthma in inhalation therapy

Yinglan Yu, Mingjie Ni, Yaxian Zheng, Yuan Huang

Journal of Controlled Release · 2024-03 · 367 · 223-234

DOI: 10.1016/j.jconrel.2024.01.044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-03. Verfasst von Yinglan Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China. Hauptthemen laut MEDLINE: Asthma, Nanoparticles. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite extensive research on corticosteroids for treating asthma, their short residence time in the lungs has limited their therapeutic effects in vivo. Nanoparticles have been widely investigated for inhaled drug delivery due to their potential benefits in prolonging drugs' residence time in the lungs. However, the retention of nanoparticles may be limited by mucus and ciliated epithelium clearance mechanisms in the airway. Herein, we anchored a neonatal-Fc-receptor-targeted peptide (FcBP) onto "mucus-penetrating" polyethylene glycol (PEG) nanoparticles (PEG-NP). Interestingly, the mucus-permeability of PEG-NP was not impaired by FcBP-functionalization. Moreover, FcBP modification enhanced cellular internalization and exocytosis via specific receptor-mediated processes, which subsequently ameliorated transepithelial transport and prolonged pulmonary retention. Importantly, after loading dexamethasone, FcBP-functionalization could effectively help nanoparticles cross the airway epithelial layer and be endocytosed by inflammatory cells, resulting in a marked decrease in inflammatory cytokines. Finally, FcBP modification significantly enhanced the therapeutic effect of dexamethasone-loaded nanoparticles in asthma mice. This study demonstrates that FcBP-functionalized PEG-NP can overcome multiple obstacles in the airway to prolong the pulmonary retention of drugs, providing a promising strategy for inhalation therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaNanoparticlesMiceAnimalsDrug Delivery SystemsMucusRespiratory TherapyDexamethasone

Stichwörter der Autor:innen

AsthmaEpithelial barrierInhalationMucus barrierNanoparticles

Substanzen

Dexamethasone

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…
  • Department of Pharmacy, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu 610031, Sichuan, China; Institute of Biomedical Engineering, College of Medicine, Southwest J…

Förderung

  • National Natural Science Foundation of China
  • Sichuan Province Science and Technology Support Program
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China

Zitieren

APA

Yu, Y., Ni, M., Zheng, Y., & Huang, Y. (2024). Airway epithelial-targeted nanoparticle reverses asthma in inhalation therapy. Journal of Controlled Release, 367, 223-234. https://doi.org/10.1016/j.jconrel.2024.01.044

Vancouver

Yu Y, Ni M, Zheng Y, Huang Y. Airway epithelial-targeted nanoparticle reverses asthma in inhalation therapy. Journal of Controlled Release. 2024;367:223-234. doi:10.1016/j.jconrel.2024.01.044

BibTeX
@article{Yu2024,
  author = {Yu, Yinglan and Ni, Mingjie and Zheng, Yaxian and Huang, Yuan},
  title = {Airway epithelial-targeted nanoparticle reverses asthma in inhalation therapy},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {367},
  pages = {223--234},
  doi = {10.1016/j.jconrel.2024.01.044}
}
Kostenlos starten →